0
United States ( Change Country )

SB 525334

Catalog No.S1476
Price Stock Quantity
$ 70
$ 120
$ 470
$ 870
 
processing...
You can order by phone, email or fax

Tel: +1-832-582-8158    Fax: +1-832-582-8590
Email: sales@selleckchem.com

Free Overnight Delivery on all orders over $ 500.

Order SB 525334 now
and get it on .

SB 525334 Chemical Structure

Recommended Products

  • SB 431542

    SB 431542 is a potent and selective inhibitor of ALK5 with an IC50 of 94 nM.

  • Crizotinib (PF-02341066)

    Inhibitor of the c-Met kinase and the NPM-ALK. Crizotinib (PF02341066) inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM).

  • TAE684 (NVP-TAE684)

    TAE684 (NVP-TAE684) is an ALK inhibitor with an IC50 between 2 and 10 nM.

  • LY2157299

    LY2157299 is a novel selective small molecule transforming growth factor beta receptor (TGF-βR) kinase inhibitor with IC50 of 86 nM and 2 nM for TβR1 and 2 nM, respectively.

  • LDN193189

    LDN193189 is a highly potent small molecule BMP inhibitor with IC50 of 5 and 30 nM for ALK2 and ALK3, respectively.

  • GSK1838705A

    GSK1838705A is a potent small-molecule IGF-IR, the insulin receptor and anaplastic lymphoma kinase (ALK) inhibitor with IC50 of 2.0, 1.6 and 0.5 nM, respectively.

  • LY2109761

    LY2109761 is a novel transforming growth factor β receptor type I and type II dual inhibitor with Ki of 38 nM and 0.3 μM, respectively.

  • GW788388

    GW788388 is a potent, selective, and orally inhibitor of ALK5 with IC50 of 18 nM.

  • CH5424802

    CH5424802 is a potent and selective ALK inhibitor with an IC50 of 1.9 nM.

Biological Activity

Information SB 525334 is a potent and selective inhibitor of the transforming growth factor-β1 (TGF-β1) receptor (activin receptor-like kinase 5, ALK5) with an IC50 of 14.3 nM.
Targets TGF-β1 (ALK5)
IC50 14.3 nM [1]
In vitro SB 525334 shows no inhibition in the enzymes ALK2, 3, and 6, with IC50 values > 10 μM. SB 525334 blocks phosphorylation induced by TGF-β1 and nuclear translocation of Smad2/3 in renal proximal tubule cells. SB 525334 also inhibits the increased mRNA expression levels of plasminogen activator inhibitor-1 (PAI-1) and procollagen α1(I) induced by TGF-β1 in A498 renal epithelial carcinoma cells at 1 μM). [1] SB 525334 (1 μM) attenuates the heightened sensitivity to TGF-β1 exhibited by pulmonary artery smooth muscle cells (PASMCs) from patients with familial forms of idiopathic pulmonary arterial hypertension (PAH). [2]
In vivo SB 525334 (10 mg/kg/day) decreases the renal mRNA levels of PAI-1, procollagen α1(I), and procollagen α1(III) in a nephritis-induced renal fibrosis rat model. Furthermore, PAN-induced proteinuria is significantly inhibited by SB 525334 (10 mg/kg/day). [1] SB 525334 may also be efficacious in mesenchymal tumors. SB 525334 (10 mg/kg/day) significantly decreases uterine mesenchymal tumor incidence, multiplicity, and size in Eker rats. [3] SB 525334 significantly reverses pulmonary arterial pressure and inhibits right ventricular hypertrophy in a rat model of PAH. This is revealed by a significant reduction in pulmonary arteriole muscularization induced by monocrotaline (used to induce PAH) after treatment with SB 525334 (3 or 30 mg/kg). [2] In a Bleomycin-induced pulmonary fibrosis mice model, SB 525334 (10 mg/kg or 30 mg/kg) attenuates the histopathological alterations in the lung, and significantly decreased mRNA expression of Type I and III procollagen and fibronectin. SB 525334 also attenuates Smad2/3 nuclear translocation, myofibroblast proliferation, deposition of Type I collagen, and decreases CTGF-expressing cells. [4]
Clinical Trials
Features

Protocol

Kinase Assay: [1]

Kinase assay to determine the potency and selectivity of SB 525334 In order to determine the potency of SB 525334, purified GST-tagged kinase domain of ALK5 is incubated with purified GST-tagged full-length Smad3 in the presence of 33P-γATP and different concentrations of SB 525334. The readout is radioactively labeled Smad3. To determine the selectivity of SB 525334, purified GST-tagged kinase domain of ALK2 and ALK4 are incubated with GST-tagged full-length Smad1 and Smad3, respectively, in the presence of different concentrations of SB 525334. IC50 values are calculated.

Cell Assay: [1]

Cell lines: Human renal proximal tubule epithelial (RPTE) cells
Concentrations: 1 μM
Incubation Time: 1 hour
Method: RPTE cells are seeded on microscope slides. The following day, the cells are starved for 24 hours to dosing by removal of the serum and epidermal growth factor. Cells are treated with either 10 ng/mL TGF-β1, 1 μM SB 525334, or a combination of both. Slides are pretreated with SB 525334 or starve media for 3 hours prior to a 1-hour incubation at 37 ℃ with TGF-β1 or starve media. The cells are then fixed and permeabilized. The slides are blocked with BSA, incubated with a mouse anti-Smad2/3 primary antibody followed by an anti-mouse IgG fluorescein secondary antibody. The slides are then viewed in a confocal microscope and nuclear signal intensity is analyzed.

Animal Study:[3]

Animal Models: Bleomycin-induced pulmonary fibrosis in female Eker rats
Formulation: 200 mg/L in drinking water
Dosages: Estimated dose of 10 mg/kg/day
Administration: Oral (in drinking water)

References

Molecular Weight (WM): 343.42
Formula:

C21H21N5

CAS No.: 356559-20-1
Synonyms:
N/A
Dissolve in (25°C): DMSO ≥69mg/mL 
Water <1mg/mL 
Ethanol ≥69mg/mL 
Storage: 2 years-20°CPowder
1 week-4°Cin DMSO
1 month-80°in DMSO

Quality Control & MSDS

View current batch:
COA H-NMR HPLC
Notes:

Related Inhibitors

Recommended Screening Libraries

Our scientific support team are available to answer any questions or queries.
Fill out an inquiry form for SB 525334 for help.

Free Sample and Reward

We give free samples and rewards to people who would like to provide us useful scientific data(western blot, etc.) > See Details

Recently Viewed Items

Keywords:buy SB 525334 | SB 525334 supplier | purchase SB 525334 | SB 525334 cost | SB 525334 manufacturer | order SB 525334 | SB 525334 distributor